Molecular classification of benign prostatic hyperplasia: A gene expression profiling study in a rat model

Area of Science:

• Urology
• Molecular Biology
• Genomics

Background:

• Benign prostatic hyperplasia (BPH) is a common condition in aging men.
• Understanding the molecular mechanisms underlying BPH progression is crucial for developing effective treatments.

Purpose of the Study:

• To characterize the molecular features of benign prostatic hyperplasia (BPH) using gene expression profiling.
• To identify potential molecular targets for BPH treatment through a rat model.

Main Methods:

• A rat model was established by implanting fetal urogenital sinus into pubertal male rats.
• Whole-genome oligonucleotide microarray analysis was performed on prostate specimens at 3 weeks post-implantation.
• Gene ontology, functional network, and pathway analyses were conducted on differentially expressed genes.

Main Results:

• Microarray analysis revealed significant upregulation (926 genes) and downregulation (3217 genes) in BPH specimens compared to normal prostate.
• Upregulated genes were predominantly associated with development, response to stimulus, and growth.
• Pathway analysis indicated activation of apoptosis modulation and signaling pathways (HSP70, interleukins, KIT) and inactivation of cholesterol biosynthesis pathways.

Conclusions:

• Gene expression profiling in a BPH rat model provides insights into the molecular mechanisms of BPH progression.
• Identified molecular signatures may serve as potential therapeutic targets for BPH treatment.